A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival.
(Q45251395)
scientific article published on 3 February 2005
scientific article published on 3 February 2005
Language: